In accordance with the Ministry of Food and Drug Safety's "Administrative Directive on Re-evaluation of Pharmaceutical Literature in 2017" (Drug Safety Evaluation Division-No. 4088, effective date 2018.07.02), the efficacy, dosage, and precautions for use of Ecrova tablets have changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.